Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome

References

• Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, Pan-Hammarström Q, Hammarström L. 2019. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 21:243.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, Tavakol M, Eslamian MH, Gharagozlou M, Movahedi M. 2018a. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 141:1450–58.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Habibi S, Gharagozlou M. 2018b. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 38:816–32.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Moin M, Kouhi A, Mohagheghi MA, Shirazi A, Rezaei N, Tavassoli S, Esfahani M, Cheraghi T, Dastan J, et al. 2008b. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 213:447–54.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Moin M, Kouhi A, Mohagheghi M-A, Shirazi A, Rezaei N, Tavassoli S, Esfahani M, Cheraghi T, Dastan J. 2008a. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 213:447–54.
   PubMed Web of Science ®Google Scholar
• Alizadeh Z, Mazinani M, Houshmand M, Shakerian L, Nourizadeh M, Pourpak Z, Fazlollahi MR. 2018. Genetic analysis of patients with two different types of hyper IgM syndrome. Immunol Invest. 47:745–53.
   PubMed Web of Science ®Google Scholar
• Alter BP. 2014. Fanconi anemia and the development of leukemia. Best Pract Res Clin Haematol. 27:214–21.
   PubMed Web of Science ®Google Scholar
• Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, Abolhassani H, Delavari S, Sohani M, Rezaei A, et al. 2020. Effect of class switch recombination defect on the phenotype of ataxia-telangiectasia patients. Immunol Invest. 1–15. doi:10.1080/08820139.2020.1723104
   PubMed Web of Science ®Google Scholar
• Azizi G, Abolhassani H, Hosein Asgardoon M, Rahnavard J, Yazdani R, Mohammadi J, Aghamohammadi A. 2016. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord-Drug Targets (Formerly Curr Drug Targets-Immune Endocr Metab Disord). 16:80–88.
   PubMed Web of Science ®Google Scholar
• Azizi G, Yazdani R. 2018. Predominantly antibody deficiencies. Immunol Genet J. 1:52–80.
   Google Scholar
• Baria K, Warren C, Roberts SA, West C, Scott D. 2001. Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer. 84:892.
   PubMed Web of Science ®Google Scholar
• Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T. 1998. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol. 8:1395–98.
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Geha RS. 2003. 12. Primary immunodeficiency diseases. J Allergy Clin Immunol. 111:S571–S81.
   PubMedGoogle Scholar
• Broaddus RR, Herzog CE, Hicks MJ. 2003. Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence. Arch Pathol Lab Med. 127:1200–03.
   PubMed Web of Science ®Google Scholar
• Conley ME, Larché M, Bonagura VR, Lawton AR, Buckley RH, Fu SM, Coustan-smith E, Herrod HG, Campana D. 1994. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest. 94:1404–09.
   PubMed Web of Science ®Google Scholar
• Davies EG, Thrasher AJ. 2010. Update on the hyper immunoglobulin M syndromes. Br J Haematol. 149:167–80.
   PubMed Web of Science ®Google Scholar
• de Miranda NF, Björkman A, Pan‐hammarström Q. 2011. DNA repair: the link between primary immunodeficiency and cancer. Ann N Y Acad Sci. 1246:50–63.
   PubMed Web of Science ®Google Scholar
• Dewire MD, Beltran C, Boop FA, Helton KJ, Ellison DW, Mckinnon PJ, Gajjar A, Panandiker ASP. 2013. Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature. J Clin Oncol. 31:e12.
   PubMed Web of Science ®Google Scholar
• Durandy A. 2008. Immunoglobulin class switch recombination: study through human natural mutants. Philos Trans R Soc B Bio Sci. 364:577–82.
   Web of Science ®Google Scholar
• Dvorak CC, Cowan MJ. 2010. Radiosensitive severe combined immunodeficiency disease. Immunol Allergy Clin. 30:125–42.
   PubMed Web of Science ®Google Scholar
• Erdős M, Garami M, Rákóczi É, Zalatnai A, Steinbach D, Baumann U, Kropshofer G, Tóth B, Maródi L. 2008. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. Clin Immunol. 129:455–61.
   PubMed Web of Science ®Google Scholar
• Gantt R, Parshad R, Price FM, Sanford KK. 1986. Biochemical evidence for deficient DNA repair leading to enhanced G2 chromatid radiosensitivity and susceptibility to cancer. Radiat Res. 108:117–26.
   PubMed Web of Science ®Google Scholar
• Gardès P, Forveille M, Alyanakian M-A, Aucouturier P, Ilencikova D, Leroux D, Rahner N, Mazerolles F, Fischer A, Kracker S. 2012. Human MSH6 deficiency is associated with impaired antibody maturation. J Immunol. 188:2023–29.
   PubMed Web of Science ®Google Scholar
• Gatti RA. 2001. The inherited basis of human radiosensitivity. Acta Oncol (Madr). 40:702–11.
   PubMed Web of Science ®Google Scholar
• Harris G, Cramp WA, Edwards JC, George AM, Sabovljev SA, Hart L, Hughes GR, Denman AM, Yatvin MB. 1985. Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med. 47:689–99.
   PubMed Web of Science ®Google Scholar
• Hauck F, Voss R, Urban C, Seidel MG. 2018. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J Allergy Clin Immunol. 141:59–68.e4.
   PubMed Web of Science ®Google Scholar
• Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy J-Y, Cosyns M, Weinberg A. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol. 158:977–83.
   PubMed Web of Science ®Google Scholar
• Hittelman WN, Pandita T. 1994. Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia. Int J Radiat Biol. 66:S109–S13.
   PubMed Web of Science ®Google Scholar
• Huo YK, Wang Z, Hong J-H, Chessa L, Mcbride WH, Perlman SL, Gatti RA. 1994. Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res. 54:2544–47.
   PubMed Web of Science ®Google Scholar
• Khorasani NR, Fekrvand S, Moghadam AD, Moazzami B. 2019. Clinical outcomes of a Cohort of patients with CD40L deficiency. Immunol Genet J. 2:114–23.
   Google Scholar
• Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, Fuleihan RL, Geha RS, Cunningham CK, Bonilla FA, Conley ME. 2016. Hyper IgM syndrome: a report from the USIDNET registry. J Clin Immunol. 36:490–501.
   PubMed Web of Science ®Google Scholar
• Levy J, Espanol-boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 131:47–54.
   PubMed Web of Science ®Google Scholar
• Li L, Ji J, Han M, Xu Y, Zhang X, Liu W, Liu S. 2020. A novel CD40L mutation associated with X-linked hyper IgM syndrome in a Chinese family. Immunol Invest. 49:307–16.
   PubMed Web of Science ®Google Scholar
• Little JB, Nagasawa H. 1985. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat Res. 101:81–93.
   PubMed Web of Science ®Google Scholar
• Mahmoodi M, Abolhassani H, Mozdarani H, Rezaei N, Azizi G, Yazdani R, Farzanfar F, Rafiemanesh H, Mohagheghi MA, Divsalar K, et al. 2018. In vitro chromosomal radiosensitivity in patients with common variable immunodeficiency. Cent-Eur J Immunol. 43:155–61.
   PubMed Web of Science ®Google Scholar
• Malhotra RK, Li W. 2008. Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated with X-linked hyperimmunoglobulin M syndrome. Arch Pathol Lab Med. 132:847–50.
   PubMed Web of Science ®Google Scholar
• Mccurdy D, Tai LQ, Frias S, Wang Z. 1997. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiat Res. 147:48–54.
   PubMed Web of Science ®Google Scholar
• Meek K, Jutkowitz A, Allen L, Glover J, Convery E, Massa A, Mullaney T, Stanley B, Rosenstein D, Bailey SM. 2009. SCID dogs: similar transplant potential but distinct intra-uterine growth defects and premature replicative senescence compared with SCID mice. J Immunol. 183:2529–36.
   PubMed Web of Science ®Google Scholar
• Milito C, Pulvirenti F, Serra G, Valente M, Pesce AM, Granata G, Catalano C, Fraioli F, Quinti I. 2015. Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies. J Clin Immunol. 35:491–500.
   PubMed Web of Science ®Google Scholar
• Mozdarani H, Bryant PE. 1989. Kinetics of chromatid aberrations in G2 ataxia-telangiectasia cells exposed to X-rays and ara A. Int J Radiat Biol. 55:71–84.
   PubMed Web of Science ®Google Scholar
• Mozdarani H, Kiaee F, Fekrvand S, Azizi G, Yazdani R, Zaki-dizaji M, Mozdarani S, Mozdarani S, Nosrati H, Abolhassani H. 2019. G2-lymphocyte chromosomal radiosensitivity in patients with LPS responsive beige-like anchor protein (LRBA) deficiency. Int J Radiat Biol. 95:680–90.
   PubMed Web of Science ®Google Scholar
• Nahas SA, Gatti RA. 2009. DNA double strand break repair defects, primary immunodeficiency disorders, and ‘radiosensitivity’. Curr Opin Allergy Clin Immunol. 9:510–16.
   PubMed Web of Science ®Google Scholar
• Ouadani H, Ben-mustapha I, Ben-ali M, Ben-khemis L, Larguèche B, Boussoffara R, Maalej S, Fetni I, Hassayoun S, Mahfoudh A. 2016. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. Immunogenet. 68:19–28.
   PubMed Web of Science ®Google Scholar
• Palanduz S, Palanduz A, Yalcin I, Somer A, Ones U, Ustek D, Ozturk S, Salman N, Guler N, Bilge H. 1998. In vitrochromosomal radiosensitivity in common variable immune deficiency. Clin Immunol Immunopathol. 86:180–82.
   PubMedGoogle Scholar
• Parshad R, Sanford KK, Jones GM. 1983. Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Nat Acad Sci. 80:5612–16.
   PubMed Web of Science ®Google Scholar
• Péron S, Metin A, Gardès P, Alyanakian M-A, Sheridan E, Kratz CP, Fischer A, Durandy A. 2008. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med. 205:2465–72.
   PubMed Web of Science ®Google Scholar
• Péron S, Pan-hammarström Q, Imai K, Du L, Taubenheim N, Sanal O, Marodi L, Bergelin-besançon A, Benkerrou M, de Villartay J-P. 2007. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair. J Exp Med. 204:1207–16.
   PubMed Web of Science ®Google Scholar
• Pietrucha BM, Heropolitanska-Pliszka E, Wakulinska A, Skopczynska H, Gatti RA, Bernatowska E. 2010. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation. J Pediatr Hematol Oncol. 32:e28–e30.
   PubMedGoogle Scholar
• Preston R. 1980. The effect of cytosine arabinoside on the frequency of X-ray-induced chromosome aberrations in normal human leukocytes. Mutat Res Fundaml Mol Mech Mutagen. 69:71–79.
   PubMed Web of Science ®Google Scholar
• Qamar N, Fuleihan RL. 2014. The hyper IgM syndromes. Clin Rev Allergy Immunol. 46:120–30.
   PubMed Web of Science ®Google Scholar
• Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A, Litzman J, Levy J, Fermand J-P, Lane P. 2004. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin immunol. 110:22–29.
   PubMed Web of Science ®Google Scholar
• Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:565–75. doi:10.1016/S0092-8674(00)00079-9.
   PubMed Web of Science ®Google Scholar
• Riballo E, Critchlow S, Teo S, Doherty A, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett C. 1999. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol. 9:699–S2.
   PubMed Web of Science ®Google Scholar
• Scott D. 1999. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol. 75:1–10.
   PubMed Web of Science ®Google Scholar
• Scott D, Barber J, Levine E, Burrill W, Roberts SA. 1998. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer. 77:614.
   PubMed Web of Science ®Google Scholar
• Scott D, Spreadborough A, Levine E, Roberts S. 1994. Genetic predisposition in breast cancer. Lancet. 344:1444.
   PubMed Web of Science ®Google Scholar
• Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, Scheible R, Rusch S, Gasteiger LM, Grimbacher B. 2019. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 7(6):1763–70.
   PubMed Web of Science ®Google Scholar
• Taylor A, Harnden D, Arlett C, Harcourt S, Lehmann A, Stevens SU, Bridges B. 1975. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258:427.
   PubMed Web of Science ®Google Scholar
• Tsai H-Y, Yu -H-H, Chien Y-H, Chu K-H, Lau Y-L, Lee J-H, Wang L-C, Chiang B-L, Yang Y-H. 2015. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients. J Microbiol Immunol Infect. 48:113–18.
   PubMedGoogle Scholar
• Vořechovský I, Scott D, Haeney MR, Webster DA. 1993. Chromosomal radiosensitivity in common variable immune deficiency. Mutat Res Fundaml Mol Mech Mutagen. 290:255–64.
   PubMed Web of Science ®Google Scholar
• Vorechovsky I, Litzman J, Lokaj J, Hausner P, Poch T. 1990. Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association. Cancer Immunol Immunother. 31:250–54.
   PubMed Web of Science ®Google Scholar
• Vorechovsky I, Munzarova M, Lokaj J. 1989. Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predisposition. Cancer Immunol Immunother. 29:303–06.
   PubMed Web of Science ®Google Scholar
• Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 82:373–84.
   PubMed Web of Science ®Google Scholar
• Yazdani R, Abolhassani H, Asgardoon MH, Shaghaghi M, Modaresi M, Azizi G, Aghamohammadi A. 2017. Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders. J Invest Allergol Clin Immunol. 27:213–24.
   PubMed Web of Science ®Google Scholar
• Yazdani R, Abolhassani H, Kiaee F, Habibi S, Azizi G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Gharagozlou M, et al. 2019. Comparison of common monogenic defects in a large predominantly antibody deficiency Cohort. J Allergy Clin Immunol Pract. 7:864–78.e9.
   PubMed Web of Science ®Google Scholar
• Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, Aghamohammadi A. 2018. The hyper IgM syndromes: epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 198:19–30.
   PubMed Web of Science ®Google Scholar